Central Nervous System Pharmacology

antidepressant

An antidepressant is a drug used to lift the persistent low mood, loss of interest, and disrupted sleep and appetite of clinical depression. Think of it less as an instant 'happy pill' and more as a slow tuning of the brain's chemical signalling that, over weeks, lets a stuck system gradually recover.

Most antidepressants increase the availability of monoamine neurotransmitters — serotonin, norepinephrine, and sometimes dopamine — at the synapse. They do this by blocking reuptake (as in SSRIs and SNRIs), blocking breakdown (as in monoamine oxidase inhibitors), or blocking certain receptors (as in mirtazapine and the older tricyclics). The neurotransmitter levels rise within hours, but mood improvement typically takes two to six weeks, pointing to slower downstream adaptations in receptors and neural circuits.

Antidepressants treat major depression and also anxiety disorders, obsessive-compulsive disorder, certain chronic pain syndromes, and more. Choice among classes is guided by side-effect profiles, safety in overdose, and individual response.

Common cautions include early increases in anxiety, sexual dysfunction, weight changes, and a discontinuation syndrome if stopped abruptly. Combining serotonergic agents can cause dangerous serotonin syndrome, and they are not addictive in the way sedatives are but should still be tapered.

A patient started on an SSRI is told that mood may not noticeably improve for several weeks, and that the dose should not be stopped suddenly even once they feel better.

Setting expectations about the slow onset improves adherence.

The delay between raised neurotransmitter levels (hours) and clinical benefit (weeks) is one of the strongest clues that depression involves more than a simple chemical shortage — adaptive changes in receptors and circuits matter too.